MESSAGE
DATE | 2006-10-18 |
FROM | Ruben Safir
|
SUBJECT | Subject: [NYLXS - HANGOUT] Re: Important Information on BIAXIN XL
|
From owner-hangout-at-mrbrklyn.com Thu Oct 19 00:52:16 2006 Received: from www2.mrbrklyn.com (localhost [127.0.0.1]) by www2.mrbrklyn.com (8.13.1/8.13.1/SuSE Linux 0.7) with ESMTP id k9J4qEUB029870 for ; Thu, 19 Oct 2006 00:52:16 -0400 Received: (from majordomo-at-localhost) by www2.mrbrklyn.com (8.13.1/8.13.1/Submit) id k9J4qEx2029869 for hangout-outgoings; Thu, 19 Oct 2006 00:52:14 -0400 X-Authentication-Warning: www2.mrbrklyn.com: majordomo set sender to owner-hangout-at-nylxs.com using -f Received: from flatbush.mrbrklyn.com (flatbush.mrbrklyn.com [10.0.0.62]) by www2.mrbrklyn.com (8.13.1/8.13.1/SuSE Linux 0.7) with ESMTP id k9J4q6Fg029865; Thu, 19 Oct 2006 00:52:08 -0400 Subject: [NYLXS - HANGOUT] Re: Important Information on BIAXIN XL From: Ruben Safir To: RXInsider In-Reply-To: <200610181557.k9IFvjjK043476-at-rxinsider1.rawdata.net> References: <200610181557.k9IFvjjK043476-at-rxinsider1.rawdata.net> Content-Type: text/plain; charset=utf-8 Date: Thu, 19 Oct 2006 00:55:03 -0400 Message-Id: <1161233703.22111.1.camel-at-flatbush.mrbrklyn.com> Mime-Version: 1.0 X-Mailer: Evolution 2.2.1 Content-Transfer-Encoding: 8bit Sender: owner-hangout-at-mrbrklyn.com Precedence: bulk X-Keywords: X-UID: 17165 Status: RO Content-Length: 4084 Lines: 93
Fuck Abbott
On Wed, 2006-10-18 at 11:57 -0400, RXInsider wrote: > Pharmacy Product > > Abbott Laboratories > 200 Abbott Park > Abbott Park, IL 60064 > > > > > > > August 30, 2006 > > Dear > Wholesaler/Retailer/Pharmacist: > > This letter is to clarify recent > events regarding the availability > of a generic version of > BIAXIN® XL (clarithromycin > extended-release). > > Abbott and Teva reached an > agreement settling our outstanding > litigation regarding BIAXIN® XL. > Per that agreement, although Teva > did ship a limited supply of > generic clarithromycin > extended-release, Teva will not > sell any additional product at this > time. Even though the court had > ordered Teva to pull its product > from the market, Abbott agreed to > allow the Teva product that had > already shipped to remain in the > market > and be distributed. > > With cold and flu season just > around the corner, incidence of > respiratory tract infections will > soon be on the rise. BIAXIN® XL > will continue to be available > exclusively from Abbott. You can > rely on Abbott to be your single > source of clarithromycin > extended-release and to supply you > with BIAXIN® XL. > > Best regards, > > Abbott Laboratories > > > > > ©2006 Abbott > Laboratories > Abbott Park, IL > 60064 > 06H-010-Q525-1 > August 2006 > > > > www.BiaxinXL.com > > > > > > > > > > > > > RXinsider.com > RXinsider LTD - 1300 > Division Rd, Suite 205, > West Warwick, RI 02893 > > Tracking > > > Advertising Information (direct email broadcasts). > Please remove my email from your list. > >
|
|